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1. Introduction 
Pottranslational modification of proteins (PTM) is involved in molecular targeting or signal 
transduction as a basis of a variety of biological processes of the cells. Approximately 300 
PTMs are existed in the cells, some of which are supposed to have important roles in cell 
physiology or embryogenesis. In addition, some modifications are reciprocally interacted, 
which regulates gene expression or protein dynamics or processing. We focus here 
polyADP-ribosylation (PARylation), which is found to contribute importantly at fertilization 
and postfertilization development. Moreover, we discuss the possible drug discovery of 
ADP-ribosylation inhibitors in carcinogenesis or fertility control.  
Upon fertilization, two kinds of genetic materials meet together to generate a new organism 
[1]. Meanwhile, the organism develops without major expression of genes from genomes. 
Although maternal proteins are supposed essential for the period, the details are ill 
understood. Transition of zygotic gene expression is also essential for further development. 
Some PTMs on transcriptional factors may be key regulation to express the genes which 
supports early development. Parental DNAs are differently regulated in the postfertilized 
eggs, although the biological significance is controversial. Theses implications suggest 
importance of PTMs on postfertilization and transition of zygotic development. Recently we 
found that PARylation, a PTM of protein is important for postfertilization development, 
which seems similar with those of carcinogenesis. 
The PARylation reaction is a PTM of proteins, which is synthesized with poly(ADP-ribose) 
polymerase (PARP) and metabolized with poly(ADP-ribose) glyceraldehyde (PARG) [2,3]. 
The reciprocal regulation is speculated as a key mechanism that underlies reversible 
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regulation of gene expression. The poly(ADP-ribose) is generated from NAD, an energy 
reservoir of the cells by PARP. The PARP synthesizes poly(ADP-ribose) using NAD. PARP 
polymerizes ADP-ribose residues to generate poly(ADP-ribose) chains onto proteins. 
PARylation reaction itself is regulated by auto-PARylation of Parp1. Since the ADP-ribose 
residue is negatively charged, the acceptor proteins become negatively charged by the 
addition of ADP-ribose residues. The electrical charge-shift of the protein induced by 
PARylation may decrease an easy access of proteins into the DNA structure or may induce 
structural instability of protein-DNA interactions, because the negative charge of poly(ADP-
ribose) supports its association with DNA-binding proteins, which are positively charged. 
The recognition of DNA sequences by protein structure may also be affected by PARylation. 
Upon postfertilization development, zygotic gene expression is essentially activated prior to 
the 4-cell cleavage stage in mice and human. Therefore, behavior of maternal molecules 
plays important roles at postfertilization development before zygotic gene activation. PTM 
of protein is supposed to contribute to protein dynamics at postfertilization development. 
Pharmacological blockage of PARylation revealed defects of postfertilization development 
in mice [4]. The data raise a question regarding the roles of PARylation at fertilization 
development. A wealth of study revealed that NAD is rich in eggs and rapidly degraded 
upon fertilization in Xenopus larvae. Parp activation at fertilization may contribute to 
consumption of NAD, which may bring a plausible explanation towards the uncovered 
subject. Postfertilization development is specific biological window to highlight the 
significance of PTM, because transcription is minor mechanisms for the organisms at the 
period. In this chapter, we discuss the roles of PARylation in eggs and the function of 
postfertilization development. Further we discuss the possible implications to drug 
discovery focusing on PARylation regulation. We focus on polyADP-ribosylation because 
we previously showed that no fertilized eggs were obtained by pharmacological blockage of 
PARylation by a PARP inhibitor, PJ-34 [4]. Other inhibitors of PARylation showed similar 
results. Therefore, a hypothesis was raised that posttranslational regulation is key regulation 
of maternal genetic materials at fertilization because no robust transcription is occurred at 
the beginning of life. 
2. PARylation in postfertilization development 
Recent research showed that pharmacological blockage of PARylation leads to defects in 
pronuclear fusion during postfertilization in mice. Based on the observations, several 
approaches were achieved to investigate the roles of PARylation in vivo and mechanisms of 
reprogramming applicable for regenerative medicines or elucidation of human diseases 
including carcinogenesis. 
Based on our observations regarding the disorganized microtubule assembly in oocytes by 
PARylation inhibitors, polyADP-ribosylated proteins of oocytes and postfertilized eggs 
were searched. We found that the tubulins (1c, 2c) [4] and glutathione S-transferees 5 
(GST5) (Osada et al., unpublished data) was highly polyADP-ribosylated after fertilization. 
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Because PARylation is known as a regulatory machinery of DNA surveillance system, this 
data provided us with a novel sight of view on the roles of PARylation regarding cell 
signaling and metabolisms. As a major upstream signaling cascade after sperm entry, MAP-
kinase (MAPK) signaling has been postulated as the key regulatory mechanism for 
pronucleus formation, and Parp1 is reported to be involved in the regulation of MAPK 
signaling [5]. Our data suggest that Parp1 is a novel nuclear component for PPN (Pseudo 
pronuclei) formation, which may be mediated by MAPK signaling. Phosphorylation level of 
Erk was decreased in the MII phase of Parp-1 null oocyte.  Because the downregulation of 
Erk phosphorylation is known to disturb microtubule organization, these results raise a 
possibility that the transient administration of a Parp inhibitor may block the early phase of 
post-fertilization process. 
Second, we focused on the roles of polyADP-ribosylation on epigenetic regulation. 
Accumulating study suggests that PARylation has a fundamental role in transcription as 
well as DNA surveillance, which mediates topological changes of the DNA structure [6,7]. 
We first examined the effects of PARylation on chromatin modification during 
postfertilization development. An immunofluorescence study using histone acetylation and 
methylation antibodies were initially carried out. Upregulation of dimethyl-H3k4 in the 
PARylation-inhibited embryos at 6 hpf, and downregulation of dimethyl-H3K9 and 
dimethyl-H3K27 at 15 hpf were observed (unpublished data, Osada et al.).  Recently, 
functional links between histone methylation and DNA methylation have been elucidated. 
Based on our observations of distinct effects of PARylation inhibition on histone 
modification regulation, we next sought for the roles of PARylation in DNA methylation. 
Global methylation of the maternal genome is maintained and sperm DNA is quickly 
demethylated during the postfertilization period [8]. The low immunoreactivity to the MetC 
antibody in the PARylation inhibited embryos was observed and it persisted at least until 15 
hpf (unpublished data, Osada et al.). The data suggest that epigenetic regulation is 
asymmetrically activated during postfertilization development, although gene expression is 
not activated. Therefore, PARylation affects the integrity of epigenetic regulation of oocytes 
and postfertilized eggs (Figure 1).  
An additional implication of this finding is that PARylation regulates the epigenetic 
nonequivalence of the pronuclei in mice. The molecular mechanisms regulating the 
asymmetric DNA methylation of one-cell embryos are largely unknown, and we showed 
that PARylation is involved in the epigenetic regulation of the mouse early development. 
PGC7/Stella-deficient eggs show similar defects in the protection of female pronuclei from 
DNA demethylation [9]. The nucleo-cytoplasmic transport of the responsible proteins 
appears to be important for the regulation of DNA methylation. The role of PARylation in 
DNA methyltransferase (DMNT) regulation is yet to be fully elucidated, although the 
interaction of DNMT1 with PARP1 and the indirect repression of DNMT1 activity by 
interacting with PAR have been suggested [10]. Based on our data showing an association 
between PARylation or PARP and histone modification, it is speculated that PARylation 
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may regulate the accessibility of DNMT or demethylase to DNA, in a manner mediated by 
chromatin remodeling. Our study provides a novel avenue for better understanding of 
establishment of chromatin organization through the histone codes and DNA methylation 
that may underlie at the beginning of zygotic development.  
 
 
 
 
 
Figure 1. Scheme of putative roles of PARylation in the chromatin dynamics of one-cell embryos. In 
the one-cell embryos (yellow circle), PARP1 may interact with histone modifying enzymes including 
Suz12, that might affect the asymmetric regulation of histone modifications in the pronuclei (male 
pronucleus in blue circle and female pronucleus in green). 
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To examine whether there is a direct or indirect linkage of epigenetic regulation with 
PARylation, we screened molecules that interacts with Parp1. To elucidate the molecular 
basis of the effect of PARylation on histone modification, we performed yeast two-hybrid 
screening using the bait vector carrying N-terminal and automodification domain. The 
Suz12, a histone methyltransferase, was identified as a candidate molecule interacting with 
Parp1 (unpublished data, Osada et al.). Suz12 is a component of PRC2/3/4 (Polycomb 
Repressive Complex 2/3/4), which regulates the repressive status of transcription by the 
methylation of histone H3K9 and H3K27. Our findings support the idea that Parp1 acts as a 
regulatory scaffold for the access of PRC2/3 to target DNA, because none of the components 
of the PRC2/3/4 complexes are DNA binding proteins. OCT4, bidirectional transcriptional 
regulator, is suggested to play a role of transcriptional regulation by recruiting PRC2/3/4 to 
the target genes, which are indispensable for the embryonic development. Modification of 
PARylation triggers loosening of chromatin structure, which may enable the access of 
transcriptional factors to DNA duplex structure.  
Third, as shown in Figure 2, defects in pronuclear formation by inhibition of PARylation 
raise a possibility that PARylation is involved in laminar formation of pronuclei [4]. In fact, 
HP1, an anchor protein of lamina and heterochromatin is polyADP-ribosylated [11]. Our 
findings showed prolonged presence of lamin-A/C, a core protein of lamina by PARP 
inhibitor PJ-34 treated eggs. Interestingly, lamin-A/C is predominantly existed in 
undifferentiated cells. Lamin-A/C is known as a marker of carcinogenesis [4]. Our 
observation provided a new insight into regulatory machinery of laminar formation in 
pluripotent cells by PARylation. Our initial data suggest that cell-cycle is not disturbed 
when embryos were subjected to treatment of PARP inhibitor. 
During the first cell cycle of mouse embryos, a few genes are transcribed mainly from 
paternal genome. Inhibition of transcription during one-cell embryos by RNA polymerase 
inhibitors showed dispensable roles of transcription in normal development. Zygotic gene 
activation is required for progression from 2-cell to 4-cell embryos. These indicate that 
posttranslational regulation of protein should act as a stem mechanism of the development 
of one-cell embryos. Upon fertilization, highly compacted chromatin of gametes was acutely 
decondensed to form pronuclei (PN) within a few hours. Protamines of sperm chromatin are 
replaced by maternal histone H1 during this process, which may be associated with global 
hypomethylation of sperm-derived PN. In contrast, maternal chromatin arrested at 
metaphase II progresses rapidly into G1 phase and subsequently forms the female PN. DNA 
synthesis from paternal genome is preceded to that from maternal DNA. A minor 
transcription is activated solely from male PN. This evidence suggests that the requirement 
for the posttranslational regulations of parental genomes before mingling of both gamete 
DNA to begin the proper zygotic development. Of posttranslational modification of 
proteins, we examined here the effects of PARylation during the first cell cycle of mouse 
embryos. Metabolism of NAD, which is the substrate of PARPs, is acutely activated upon 
fertilization. Further analysis will elucidate the biological functions of PARylation upon 
fertilization and downstream target molecules of them. 
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Figure 2. Model for regulation of pre- and postfertilization process by PARylation. Biological 
processes occurred during pre- and postfertilization were shown. Putative correlation with polyADP-
ribosylation were indicated in red. 
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3. Implication towards reprogramming 
In 1997, the first cloned animals were generated [12]. Cytogenetic analyses have shown that 
karyotypic aberrations occur in cloned embryos during the first mitotic cleavage. Epigenetic 
errors in cloned animals are also argued to be the major reason for the limited success rates 
of cloned animal births. However, whether genome-wide chromatin remodeling during 
nuclear reprogramming causes DNA damage, or whether defects in DNA repair cause the 
inefficiency of cloned animal births have not been investigated. Recently, it was reported 
that double strand break (DSB)–mediated chromatin remodeling regulates transcription, 
and that Parp1 is critically involved in this process. Various roles for Parp1 have been 
described, including in the chromatin remodeling involved in transcriptional regulation 
[2,3]. The roles of Parp1 in NT-embryo development in the contexts of DNA repair and 
chromatin remodeling was examined. To do this, we used Parp1-null mutant cells as 
recipient oocytes and as a source of donor nuclei. 
We observed that the activation process in NT eggs was enhanced in Parp1–null NT 
embryos, although some genomic instability was observed (Osada T., unpublished data). 
Dynamic changes in histone acetylation and methylation were induced under Parp-1 
deficiency in NT embryos (Figure 3). The lack of Parp1 may thus facilitate chromatin 
condensation or transcriptional silencing. Parp1 is involved in both the regulation of DNA 
strand break repair and the epigenetic control of gene expression. Our findings suggest that 
Parp1 is important for chromatin remodeling possibly through histone modification during 
the nuclear reprogramming of NT embryos. The phosphorylation of histone H2AX at DSBs 
is believed to be crucial for the recognition and repair of DNA damage. The foci-like 
presence of H2AX in the NT embryos implied that DNA repair was taking place in the 
PNN. H2AX is a direct target of ATM kinase, which is expressed at the spindle of MII 
oocytes, and Parp1 interacts with ATM. The prolongation of the H2AX foci in the Parp1-/- 
NT embryos could therefore be related to a delay in repairing DNA strand breaks, as is the 
case with Parp1-/-  MEF and ES cells, which show prolonged H2AX foci after DNA damage 
induced by neocartinostatin. In Parp1-/- NT embryos, mitotic arrest of embryogenesis at the 
2-4-cell stage was frequently observed, accompanied by polynucleated blastomeres. Since 
Parp1 is located in centrosomes as well as in nuclei, the lack of Parp1 may have disturbed 
the normal cell division cycle and the synchronous pattern of cell division among the 
blastomeres. Transient Parp-1 functional inhibition may be therefore useful to improve the 
efficiency of NT by modulating the dynamic organization of chromatin without causing 
genomic instability. 
4. Implication towards human diseases 
PARylation has been known to possess important roles in carcinogenesis. PARP mainly 
affects DNA surveillance system in the cells, which deficit increases the risk of 
carcinogenesis. In addition, recent study showed a functional relationship between PARP 
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and MAPK signaling, known as a major intracellular signaling of transformation into cancer 
cells. Although morphological change of nuclear envelope has been known in cancer cells, 
the molecular mechanism of the processes is not well understood. Recent studies revealed 
molecular signaling of laminar formation is altered during carcinogenesis. Our study 
revealed that PARylation is involved in these molecular events. Oocytes are capable of 
being isolated without other cell types by adding hyarulonidase, which is far easier 
compared with the difficulty in homogenous isolation of purified cancer cells. Our data 
suggest oocytes provide with a unique biological window for elucidating the mechanism 
of PARylation in carcinogenesis. Further comparative analysis between cancer cells and 
oocytes may highlight the uncovered mechanisms underlying the carcinogenesis 
processes.  
 
 
 
 
 
 
 
 
Figure 3. The scheme of histone modification and the effects of Parp1 deficiency during the first 
cleavage of NT embryogenesis. Histone modifications of the one-cell reconstructed oocytes were 
indicated in Parp+/+, and  those which Parp1 deficiency influences were indicated in Parp-/- in red. 
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We also described here that PARylation is a novel target of anti-conception. Inhibition of 
PARylation may easy to be handled, because exposure of an inhibitor to oocytes is effective 
enough to stop fertilization. Further extensive analysis should be carried out regarding the 
optimized dose of inhibitors and non-toxic dose on other tissues. Biological phenomena, in 
which PARylation is involved, are variable and its inhibitors could serve as possible 
pharmaceutical targets including inflammation or brain injury as well as carcinogenesis and 
reproduction as discussed in this chapter. Further basic investigation of the roles of 
PARylation in the cells will broaden the view for the understanding the embryogenesis and 
proof of mechanism of human diseases for drug discovery.   
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